+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 70Years
All Genders
Healthy Volunteers
ID05187091

Comparing Swallowing-Sparing and Standard Intensity-Modulated Radiotherapy for Head and Neck Squamous Cell Carcinomas Including Oropharynx, Larynx, and Hypopharynx

Led by All India Institute of Medical Sciences · Updated on 2026-09-11

136

Participants Needed

1

Research Sites

15 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new way to deliver radiation therapy for patients with head and neck squamous cell carcinomas HNSCC in the oropharynx, larynx, and hypopharynx. This trial compares standard intensity-modulated radiotherapy IMRT with a specialized approach called SWOAR IMRT that aims to protect swallowing and aspiration-related structures and the contralateral submandibular gland. The goal is to reduce swallowing difficulties and aspiration risks after treatment. Participants will be randomly assigned to receive either the standard IMRT combined with chemotherapy or the SWOAR IMRT with chemotherapy. Cisplatin chemotherapy is given weekly during radiation at a specified dose when indicated. Both treatments involve radical concurrent chemoradiotherapy or radiotherapy planned for the tumor and lymph nodes. The trial follows patients over time to compare effects on swallowing and other outcomes. Participants will complete questionnaires assessing swallowing function and quality of life before treatment, at the end of treatment, and at multiple follow-up points up to two years. Swallowing safety will also be measured using specialized endoscopic exams. Researchers will monitor treatment side effects weekly during radiation and at follow-up visits. Tumor control and overall survival will be assessed up to five years after treatment, with long-term toxicity and quality of life evaluations included.

CONDITIONS

Brief Title

The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas

Research Team

A

Aman Sharma, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here